AnalystBook Research · Company Intelligence

Aterian, Inc.

ATERNasdaq

Built from Aterian, Inc.'s own SEC filings · updates as new filings land · sources cited throughout

or browse all covered companies

Aterian revenue fell 30.4% to $69.0M, losses widened, FCF swung negative, and equity fell by nearly half.

The read at a glance✓ Audited against SEC data
  • Business mixOnline consumer productsNote
  • RevenueRevenue fell 30.4%Watch
  • LossesNet loss widened to $19.0MWatch
  • CashFCF was -$10.9MWatch
  • Balance sheetEquity fell 49.3%Watch
  • Insiders0 buys / 0 sellsNote
  • AccountingAltman-Z distress; EQ greyWatch

Business

Aterian is a consumer products company selling owned brands through online retail channels such as Amazon, Walmart, Target, and direct websites.

Where the revenue comes from

Fiscal 2025, as Aterian, Inc. reports it. History and quarterly detail are in the app.

  • Housewares$14.9M
  • Heating, Cooling, and Air Quality$13.9M
  • Essential Oils and Related Accessories$12.1M
  • Health and Beauty$10.6M
  • Kitchen Appliances$8.5M

Leadership changes

From Aterian, Inc.'s own filings, the day they're filed.

  • Arturo Rodriguez · CEO · appointment

Latest filings

  • 10-Q · Quarterly report2026-08-14
  • 8-K · Company announcement2026-07-20
  • 8-K · Company announcement2026-07-10
  • 8-K · Company announcement2026-06-26
  • 8-K · Company announcement2026-05-21
In the full recordFree for 14 days
  • What changed🔒
  • Insider signal🔒
  • Growth quality🔒
  • Margins & accounting🔒
  • Capital allocation🔒
  • Real risks🔒
  • The long arc🔒
  • Company history🔒
  • Main tension🔒
  • The filings, readable — with what changed vs the prior year highlighted🔒
  • Full financial statements, industry-aware, sources cited throughout🔒
  • Forensic score history & components — the trend, not one year🔒
  • Ownership: insider buys/sells, clusters, activist stakes🔒
  • Ana — ask about Aterian, Inc., every answer cited to the official filings🔒

Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.

14-day free trial, no credit card. For research purposes only; not investment advice.